Jeil Pharma Holdings (XKRX:002620) Days Sales Outstanding : 79.91 (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Days Sales Outstanding?

Jeil Pharma Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was ₩177,705 Mil. Jeil Pharma Holdings's Revenue for the three months ended in Dec. 2023 was ₩202,931 Mil. Hence, Jeil Pharma Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 79.91.

The historical rank and industry rank for Jeil Pharma Holdings's Days Sales Outstanding or its related term are showing as below:

XKRX:002620' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.83 Med: 99.04 Max: 1718.25
Current: 77.72

During the past 13 years, Jeil Pharma Holdings's highest Days Sales Outstanding was 1718.25. The lowest was 71.83. And the median was 99.04.

XKRX:002620's Days Sales Outstanding is ranked worse than
55.64% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs XKRX:002620: 77.72

Jeil Pharma Holdings's Days Sales Outstanding increased from Dec. 2022 (79.64) to Dec. 2023 (79.91).

Jeil Pharma Holdings Days Sales Outstanding Historical Data

The historical data trend for Jeil Pharma Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Days Sales Outstanding Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

84.02

78.19

74.60

71.83

77.36

Jeil Pharma Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															79.64	74.32	77.40	79.74	79.91

Competitive Comparison of Jeil Pharma Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Jeil Pharma Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jeil Pharma Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jeil Pharma Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jeil Pharma Holdings's Days Sales Outstanding falls into.

Jeil Pharma Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jeil Pharma Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (162403.36	+	178437.277)	/	2 )	/	804043.002	*	365
=	170420.3185					/	804043.002	*	365
=	77.36

Jeil Pharma Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (176972.613	+	178437.277)	/	2 )	/	202931.172	*	365 / 4
=	177704.945					/	202931.172	*	365 / 4
=	79.91

Jeil Pharma Holdings (XKRX:002620) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Jeil Pharma Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines